Brucellosis, caused by Brucella abortus, has been eliminated from livestock in the US. Remaining wildlife reservoirs are the bison (Bison bison) and elk (Cervus canadensis) populations in Yellowstone National Park and the surrounding area, from which there is periodic exposure and transmission to surrounding livestock herds. Elk account for nearly all of the livestock exposure, and the infection appears to be expanding in the elk population. Currently, there are no known effective vaccines for brucellosis in elk. We conducted three experiments to evaluate the efficacy and practicality of delivering a killed B. abortus vaccine compounded with montmorillonite clay as a carrying agent to oral, nasal, and conjunctival mucosa. The first study, conducted in laboratory mice (Mus musculus), demonstrated protection against infection equal to that produced by the currently approved cattle (Bos taurus) vaccine RB51. The second experiment, conducted as a pilot study in a small sample of elk, demonstrated partial protection against B. abortus infection. Results of the third experiment showed that elk consumed the majority of a surrogate vaccine compounded with montmorillonite mixed in hay with oral, nasal, conjunctival, and gastrointestinal exposure to the vaccine. These results suggest that multiple exposures to a mucosally delivered vaccine may provide an effective method of vaccinating wildlife.
How to translate text using browser tools
9 October 2019
PARTIAL PROTECTION IN BALB/C HOUSE MICE (MUS MUSCULUS) AND ROCKY MOUNTAIN ELK (CERVUS CANADENSIS) AFTER VACCINATION WITH A KILLED, MUCOSALLY DELIVERED BRUCELLA ABORTUS VACCINE
Jack Rhyan,
Pauline Nol,
Morgan Wehtje,
Angela Bosco-Lauth,
Nicole Marlenee,
Matt McCollum,
Samantha Bruce,
Airn Hartwig,
Scott Stelting,
Suelee Robbe-Austerman,
Richard Bowen
ACCESS THE FULL ARTICLE
![](/ContentImages/journals/jwdi/55/4/4/WebImages/140.055.0400.cover.jpg)
Journal of Wildlife Diseases
Vol. 55 • No. 4
October 2019
Vol. 55 • No. 4
October 2019
Brucella abortus
elk
montmorillonite
Mouse
mucosal
oral
vaccine